Intrapulmonary administration of recombinant activated factor VII in diffuse alveolar haemorrhage: a report of two case stories

BACKGROUND: Diffuse alveolar haemorrhage (DAH) is a serious pulmonary complication characterised by a high mortality rate and the absence of specific treatment. The intrapulmonary administration of activated recombinant factor VII (rFVIIa) in DAH was recently published in six patients by Heslet et a...

Descripción completa

Detalles Bibliográficos
Autores principales: Estella, Ángel, Jareño, Antonio, Perez-Bello Fontaiña, Luis
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2551590/
https://www.ncbi.nlm.nih.gov/pubmed/18789132
http://dx.doi.org/10.1186/1757-1626-1-150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2551590/
https://www.ncbi.nlm.nih.gov/pubmed/18789132
http://dx.doi.org/10.1186/1757-1626-1-150

Ejemplares similares